Literature DB >> 26235210

Critical roles of co-activation receptor DNAX accessory molecule-1 in natural killer cell immunity.

Peng Xiong1, Hai-Wei Sang1, Min Zhu1.   

Abstract

Natural killer (NK) cells, which can exert early and powerful anti-tumour and anti-viral responses, are important components of the innate immune system. DNAX accessory molecule-1 (DNAM-1) is an activating receptor molecule expressed on the surface of NK cells. Recent findings suggest that DNAM-1 is a critical regulator of NK cell biology. DNAM-1 is involved in NK cell education and differentiation, and also plays a pivotal role in the development of cancer, viral infections and immune-related diseases. However, tumours and viruses have developed multiple mechanisms to evade the immune system. They are able to impair DNAM-1 activity by targeting the DNAM-1 receptor-ligand system. We have reviewed the roles of DNAM-1, and its biological functions, with respect to NK cell biology and DNAM-1 chimeric antigen receptor-based immunotherapy.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  DNAM-1; DNAM-1 ligands; infections; natural killer cells; tumours

Mesh:

Substances:

Year:  2015        PMID: 26235210      PMCID: PMC4610626          DOI: 10.1111/imm.12516

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  98 in total

1.  Coordinated expression of DNAM-1 and LFA-1 in educated NK cells.

Authors:  Monika Enqvist; Eivind Heggernes Ask; Elin Forslund; Mattias Carlsten; Greger Abrahamsen; Vivien Béziat; Sandra Andersson; Marie Schaffer; Anne Spurkland; Yenan Bryceson; Björn Önfelt; Karl-Johan Malmberg
Journal:  J Immunol       Date:  2015-03-30       Impact factor: 5.422

Review 2.  Oncogenic stress sensed by the immune system: role of natural killer cell receptors.

Authors:  David H Raulet; Nadia Guerra
Journal:  Nat Rev Immunol       Date:  2009-08       Impact factor: 53.106

Review 3.  Human NK cells and NK receptors.

Authors:  Francesca Bellora; Roberta Castriconi; Alessandra Dondero; Paolo Carrega; Alberto Mantovani; Guido Ferlazzo; Alessandro Moretta; Cristina Bottino
Journal:  Immunol Lett       Date:  2013-12-19       Impact factor: 3.685

4.  The human ortholog of granulocyte macrophage colony-stimulating factor and interleukin-2 fusion protein induces potent ex vivo natural killer cell activation and maturation.

Authors:  Claudia Penafuerte; Norma Bautista-Lopez; Mohamed-Rachid Boulassel; Boulassel Mohamed-Rachid; Jean-Pierre Routy; Jacques Galipeau
Journal:  Cancer Res       Date:  2009-11-17       Impact factor: 12.701

Review 5.  DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins.

Authors:  Lucas Ferrari de Andrade; Mark J Smyth; Ludovic Martinet
Journal:  Immunol Cell Biol       Date:  2013-12-17       Impact factor: 5.126

6.  CD8 T cell defect of TNF-α and IL-2 in DNAM-1 deficient mice delays clearance in vivo of a persistent virus infection.

Authors:  Megan J Welch; John R Teijaro; Hanna A Lewicki; Marco Colonna; Michael B A Oldstone
Journal:  Virology       Date:  2012-05-12       Impact factor: 3.616

Review 7.  The role of natural killer cells in sepsis.

Authors:  Laurent Chiche; Jean-Marie Forel; Guillemette Thomas; Catherine Farnarier; Fréderic Vely; Mathieu Bléry; Laurent Papazian; Eric Vivier
Journal:  J Biomed Biotechnol       Date:  2011-05-14

8.  TLiSA1, a human T lineage-specific activation antigen involved in the differentiation of cytotoxic T lymphocytes and anomalous killer cells from their precursors.

Authors:  G F Burns; T Triglia; J A Werkmeister; C G Begley; A W Boyd
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

9.  Accelerated tumor growth in mice deficient in DNAM-1 receptor.

Authors:  Akiko Iguchi-Manaka; Hirayasu Kai; Yumi Yamashita; Kai Shibata; Satoko Tahara-Hanaoka; Shin-ichiro Honda; Teruhito Yasui; Hitoshi Kikutani; Kazuko Shibuya; Akira Shibuya
Journal:  J Exp Med       Date:  2008-11-24       Impact factor: 14.307

10.  CD226 rs763361 is associated with the susceptibility to type 1 diabetes and greater frequency of GAD65 autoantibody in a Brazilian cohort.

Authors:  Teresa Cristina Colvara Mattana; Aritania Sousa Santos; Rosa Tsuneshiro Fukui; Debora Teixeira Oliveira Mainardi-Novo; Vinícius Silva Costa; Rosa Ferreira Santos; Sergio Russo Matioli; Maria Elizabeth Rossi da Silva
Journal:  Mediators Inflamm       Date:  2014-05-07       Impact factor: 4.711

View more
  7 in total

1.  Lung Cancer Induces NK Cell Contractility and Cytotoxicity Through Transcription Factor Nuclear Localization.

Authors:  Darren Chen Pei Wong; E Hui Clarissa Lee; Junzhi Er; Ivan Yow; Ricky Abdi Gunawan Koean; Owen Ang; Jingwei Xiao; Boon Chuan Low; Jeak Ling Ding
Journal:  Front Cell Dev Biol       Date:  2022-05-16

Review 2.  Granule-Dependent Natural Killer Cell Cytotoxicity to Fungal Pathogens.

Authors:  Henry Ogbomo; Christopher H Mody
Journal:  Front Immunol       Date:  2017-01-11       Impact factor: 7.561

3.  CD226 regulates natural killer cell antitumor responses via phosphorylation-mediated inactivation of transcription factor FOXO1.

Authors:  Xiangnan Du; Patricia de Almeida; Nick Manieri; Denise de Almeida Nagata; Thomas D Wu; Kristin Harden Bowles; Vidhyalakshmi Arumugam; Jill Schartner; Rafael Cubas; Stephanie Mittman; Vincent Javinal; Keith R Anderson; Søren Warming; Jane L Grogan; Eugene Y Chiang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-30       Impact factor: 11.205

4.  Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma.

Authors:  Josep Corominas; Victor Sapena; Marco Sanduzzi-Zamparelli; Cristina Millán; Esther Samper; Neus Llarch; Gemma Iserte; Ferràn Torres; Leonardo G Da Fonseca; Sergio Muñoz-Martínez; Alejandro Forner; Jordi Bruix; Loreto Boix; María Reig
Journal:  Cancers (Basel)       Date:  2021-01-23       Impact factor: 6.639

5.  DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells in vitro: a proof-of-concept study.

Authors:  Chiara Focaccetti; Monica Benvenuto; Chiara Pighi; Alessandra Vitelli; Federico Napolitano; Nicola Cotugno; Doriana Fruci; Paolo Palma; Paolo Rossi; Roberto Bei; Loredana Cifaldi
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

Review 6.  Natural Killer Cell Recognition of Melanoma: New Clues for a More Effective Immunotherapy.

Authors:  Raquel Tarazona; Esther Duran; Rafael Solana
Journal:  Front Immunol       Date:  2016-01-07       Impact factor: 7.561

Review 7.  Engineering of chimeric natural killer cell receptors to develop precision adoptive immunotherapies for cancer.

Authors:  J Obajdin; D M Davies; J Maher
Journal:  Clin Exp Immunol       Date:  2020-07-25       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.